Cross-reactivity between vancomycin, teicoplanin, and telavancin in patients with HLA-A?32:01–positive vancomycin-induced DRESS sharing an HLA class II haplotype - 09/01/21

Nontaya Nakkam, PhD ^{a, b}, Andrew Gibson, PhD ^c, Effie Mouhtouris, BSc ^d, Katherine C. Konvinse, PhD ^b, Natasha E. Holmes, MBBS, PhD ^d, Kyra Y. Chua, MBBS, PhD ^d, Pooja Deshpande, PhD ^{c, e}, Danmeng Li, MD ^f, David A. Ostrov, PhD ^f, Jason Trubiano, MBBS, PhD ^{d, g}, Elizabeth J. Phillips, MD ^{b, c}

^a Department of Pharmacology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand 

^b Vanderbilt University Medical Center, Nashville, Tenn 

^c Institute for Immunology and Infectious Diseases, Murdoch University, Perth, Australia 

^d Department of Infectious Diseases, Austin Health, University of Melbourne, Melbourne, Australia 

^e School of Human Sciences, University of Western Australia, Western Australia, Australia 

^f Department of Pathology, Immunology, and Laboratory Medicine, University of Florida College of Medicine, Gainesville, Fla 

^g Peter McCallum Cancer Centre, Melbourne, Australia